Eva Poveda

4.8k total citations
141 papers, 3.0k citations indexed

About

Eva Poveda is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Eva Poveda has authored 141 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Infectious Diseases, 80 papers in Virology and 65 papers in Epidemiology. Recurrent topics in Eva Poveda's work include HIV/AIDS drug development and treatment (84 papers), HIV Research and Treatment (80 papers) and Hepatitis C virus research (54 papers). Eva Poveda is often cited by papers focused on HIV/AIDS drug development and treatment (84 papers), HIV Research and Treatment (80 papers) and Hepatitis C virus research (54 papers). Eva Poveda collaborates with scholars based in Spain, United States and Sierra Leone. Eva Poveda's co-authors include Vincent Soriano, Verónica Briz, Carmen de Mendoza, Pablo Barreiro, Eugenia Vispo, María del Mar González, Álvaro Mena, Luz Martı́n-Carbonero, Ángeles Castro‐Iglesias and Juan González‐Lahoz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Eva Poveda

138 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Poveda Spain 33 1.9k 1.6k 1.2k 1.0k 336 141 3.0k
Eoin Coakley United States 27 1.7k 0.9× 1.5k 1.0× 1.3k 1.1× 1.2k 1.2× 372 1.1× 66 3.2k
M. Michelle Berrey United States 22 1.3k 0.7× 1.3k 0.8× 1.5k 1.3× 1.5k 1.5× 272 0.8× 35 3.0k
Ralph DeMasi United States 25 2.6k 1.4× 2.3k 1.4× 752 0.6× 520 0.5× 422 1.3× 82 3.7k
Christoph Boesecke Germany 29 1.4k 0.7× 679 0.4× 1.5k 1.2× 1.1k 1.0× 203 0.6× 141 2.8k
Pompeyo Viciana Spain 31 1.7k 0.9× 1.2k 0.7× 1.1k 0.9× 446 0.4× 226 0.7× 131 2.9k
Luís F. López‐Cortés Spain 29 1.4k 0.7× 631 0.4× 1.5k 1.2× 1.1k 1.0× 162 0.5× 155 2.8k
Andrzej Horban Poland 34 2.1k 1.1× 1.2k 0.8× 2.4k 2.0× 2.2k 2.1× 396 1.2× 183 4.6k
Maureen Myers United States 24 2.4k 1.3× 1.7k 1.0× 1.4k 1.2× 875 0.9× 387 1.2× 36 3.8k
Jason T. Blackard United States 31 823 0.4× 766 0.5× 1.8k 1.5× 1.9k 1.9× 239 0.7× 151 3.1k
Tara L. Kieffer United States 28 2.2k 1.2× 1.3k 0.8× 2.7k 2.2× 3.0k 2.9× 489 1.5× 61 4.6k

Countries citing papers authored by Eva Poveda

Since Specialization
Citations

This map shows the geographic impact of Eva Poveda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Poveda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Poveda more than expected).

Fields of papers citing papers by Eva Poveda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Poveda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Poveda. The network helps show where Eva Poveda may publish in the future.

Co-authorship network of co-authors of Eva Poveda

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Poveda. A scholar is included among the top collaborators of Eva Poveda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Poveda. Eva Poveda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gutiérrez‐Valencia, Alicia, Ana Mariño, Alexandre Pérez‐González, et al.. (2023). IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors. Frontiers in Immunology. 14. 1257725–1257725. 4 indexed citations
2.
Leiro‐Fernández, Virginia, et al.. (2023). High Levels of IL-1β, TNF-α and MIP-1α One Month after the Onset of the Acute SARS-CoV-2 Infection, Predictors of Post COVID-19 in Hospitalized Patients. Microorganisms. 11(10). 2396–2396. 14 indexed citations
3.
Trujillo‐Rodríguez, María, Ana Serna‐Gallego, Juan Manuel Praena‐Fernández, et al.. (2022). Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients. PLoS ONE. 17(7). e0269875–e0269875. 1 indexed citations
4.
Viéitez, Irene, Alicia Gutiérrez‐Valencia, Vasso Skouridou, et al.. (2021). Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19. Microorganisms. 9(11). 2259–2259. 16 indexed citations
5.
Yendewa, George A., Sulaiman Lakoh, Hannah Lawrence, et al.. (2020). Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional study. International Journal of Infectious Diseases. 102. 45–52. 14 indexed citations
6.
Poveda, Eva, Wendy Fitzgerald, Ángel Salgado‐Barreira, et al.. (2020). Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control. The Journal of Infectious Diseases. 225(6). 1040–1049. 15 indexed citations
7.
Poveda, Eva, et al.. (2018). HIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic. PubMed. 20(2). 104–113. 20 indexed citations
8.
Pernas, Berta, Sónia Pértega-Díaz, Ángeles Castro‐Iglesias, et al.. (2015). Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?. Journal of Antimicrobial Chemotherapy. 71(4). 1051–1055. 19 indexed citations
9.
Paraskevis, Dimitrios, Evangelia Georgia Kostaki, Apostolos Beloukas, et al.. (2014). Molecular characterization of HIV-1 infection in Northwest Spain (2009–2013): Investigation of the subtype F outbreak. Infection Genetics and Evolution. 30. 96–101. 16 indexed citations
10.
García, Féderico, Eva Poveda, Maria Jesús Pérez‐Elías, et al.. (2014). Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48‐week analysis of the PROTEST study. Journal of the International AIDS Society. 17(4S3). 19520–19520. 1 indexed citations
11.
Poveda, Eva, David Wyles, Álvaro Mena, et al.. (2014). Update on hepatitis C virus resistance to direct-acting antiviral agents. Antiviral Research. 108. 181–191. 160 indexed citations
12.
Soriano, Vincent, Pablo Labarga, José Vicente Fernández-Montero, et al.. (2012). The changing face of hepatitis C in the new era of direct-acting antivirals. Antiviral Research. 97(1). 36–40. 24 indexed citations
13.
Seclén, Eduardo, Vincent Soriano, María del Mar González, Juan González‐Lahoz, & Eva Poveda. (2011). Short Communication: Severe Immune Suppression in Patients Infected with R5-Tropic HIV-1 Strains Is Associated with Increased gp120 Net Charge at Variable Regions. AIDS Research and Human Retroviruses. 27(9). 965–967. 7 indexed citations
14.
Soriano, Vincent, María del Mar González, Federico A. Di Lello, et al.. (2011). Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients. Journal of Antimicrobial Chemotherapy. 66(12). 2838–2842. 19 indexed citations
15.
Briz, Verónica, Carmen Garrido, Eva Poveda, et al.. (2009). Raltegravir and Etravirine Are Active against HIV Type 1 Group O. AIDS Research and Human Retroviruses. 25(2). 225–227. 31 indexed citations
16.
Mendoza, Carmen de, et al.. (2008). Resistencia viral y barrera genética de atazanavir. Enfermedades Infecciosas y Microbiología Clínica. 26. 28–33.
17.
Poveda, Eva, et al.. (2007). Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use. AIDS. 21(11). 1487–1490. 39 indexed citations
18.
Poveda, Eva, Pablo Barreiro, Berta Rodés, & Vincent Soriano. (2005). Enfuvirtide Is Active against HIV Type 1 Group O. AIDS Research and Human Retroviruses. 21(6). 583–585. 25 indexed citations
19.
Toro, Carlos, Berta Rodés, Eva Poveda, et al.. (2003). Transmission of HIV Type 1 through Blood Transfusion from an Antibody-Negative/p24 Antigen-Negative Donor. AIDS Research and Human Retroviruses. 19(6). 447–448. 3 indexed citations
20.
Poveda, Eva, et al.. (2003). Can Drug Resistance Mutations Influence the Measurement of Plasma HIV-RNA by Different Viral Load Techniques?. AIDS Patient Care and STDs. 17(7). 321–324. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eoin Coakley Breakdown of academic impact, for papers by M. Michelle Berrey Breakdown of academic impact, for papers by Ralph DeMasi Breakdown of academic impact, for papers by Christoph Boesecke Breakdown of academic impact, for papers by Pompeyo Viciana Breakdown of academic impact, for papers by Luís F. López‐Cortés Breakdown of academic impact, for papers by Andrzej Horban Breakdown of academic impact, for papers by Maureen Myers Breakdown of academic impact, for papers by Jason T. Blackard Breakdown of academic impact, for papers by Tara L. Kieffer
Rankless by CCL
2026